Kamyar Shameli: Understanding the Coagulation Cascade – How Anticoagulants Prevent Blood Clots
Kamyar Shameli, Senior Scientist at Technical University of Munich, shared a post on LinkedIn:
“Understanding the Coagulation Cascade: How Anticoagulants Prevent Blood Clots
Description: The blood coagulation cascade is a precise, multi-step enzymatic process designed to prevent blood loss while keeping blood flowing safely through our vessels. At the center of this cascade is a critical turning point where multiple pathways converge: Factor Xa and Thrombin.
Here is how the coagulation cascade works and how anticoagulant therapies interrupt it:
The Conversion Mechanism
When coagulation is activated, Factor Xa converts Prothrombin into active Thrombin. Thrombin serves as the central key enzyme that drives the formation of Fibrin, creating a structural mesh that locks red blood cells and platelets into a stable clot.
How Anticoagulants Work: Anticoagulants interrupt this cascade by targeting key enzymes:
Direct Factor Xa Inhibitors amp; Direct Thrombin Inhibitors: Bind directly to Factor Xa or Thrombin to block their activity.
Heparin amp; Antithrombin Complex: Potentiate the bodys natural antithrombin mechanisms to neutralize Factor Xa and Thrombin.
Clinical Outcome
By reducing Factor Xa and Thrombin activity, fibrin formation drops significantly. This reduces the bodys ability to form and extend pathologically stable blood clots, helping prevent conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 22:34Hasan Abbas Zaheer: Honoured to Have Co-Authored One of the Four Reviews in The Lancet Thalassemia Series
-
Oct 5, 2026, 22:31Risika Samanta: Pediatric ITP in a 12-year-old – An Atypical Presentation without a Viral Prodrome
-
Oct 5, 2026, 22:25Allie Boutin: Raising Awareness and Supporting the Community During ITP Awareness Month
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies